We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPX icon
7676
Riley Exploration Permian
REPX
$744M
$18K ﹤0.01%
1,899
-1,434
-43% -$11.6K
SLS icon
7677
SELLAS Life Sciences
SLS
$1.97B
$18K ﹤0.01%
45
+26
+137% +$12.6K
VTNR
7678
DELISTED
Vertex Energy, Inc
VTNR
$18K ﹤0.01%
+19,600
New +$16.6K
STAF
7679
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$18K ﹤0.01%
9
+3
+50% +$6.41K
SSI
7680
DELISTED
Stage Stores Inc
SSI
$18K ﹤0.01%
+10,534
New +$19.4K
RAS
7681
PUT
DELISTED
RAIT Financial Trust
RAS
$18K ﹤0.01%
47,100
-14,600
-24% -$6.59K
CCIH
7682
CALL
DELISTED
Chinacache International Holdings Ltd
CCIH
$18K ﹤0.01%
+10,400
New +$12.2K
EYPT icon
7683
EyePoint Inc
EYPT
$1.03B
$17K ﹤0.01%
1,569
-238
-13% -$2.86K
TRAW icon
7684
Traws Pharma
TRAW
$6.85M
$17K ﹤0.01%
+2
New +$20.6K
ENG
7685
DELISTED
ENGlobal Corp
ENG
$17K ﹤0.01%
+2,414
New +$18.8K
TRVN
7686
DELISTED
Trevena, Inc.
TRVN
$17K ﹤0.01%
+17
New +$18.5K
SUNW
7687
DELISTED
Sunworks, Inc.
SUNW
$17K ﹤0.01%
+2,351
New +$20.1K
SSI
7688
PUT
DELISTED
Stage Stores Inc
SSI
$17K ﹤0.01%
+10,100
New +$18.6K
GNCA
7689
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$17K ﹤0.01%
+1,788
New +$18K
WMGIZ
7690
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$17K ﹤0.01%
11,232
-14,691
-57% -$22.7K
CRVP
7691
DELISTED
Crystal Rock Holdings, Inc.
CRVP
$17K ﹤0.01%
20,621
+1,370
+7% +$1.02K
RMGN
7692
DELISTED
RMG Networks Holding Corporation
RMGN
$17K ﹤0.01%
+21,040
New +$27.6K
CYTR
7693
CALL
DELISTED
CytRx Corp
CYTR
$17K ﹤0.01%
10,300
+6,917
+204% +$14.3K
NIHD
7694
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$17K ﹤0.01%
38,932
+7,725
+25% +$2.92K
CAPR icon
7695
Capricor Therapeutics
CAPR
$223M
$16K ﹤0.01%
+1,001
New +$21.7K
FWDI
7696
Forward Industries Inc
FWDI
$297M
$16K ﹤0.01%
+1,325
New +$16.6K
PHIO icon
7697
Phio Pharmaceuticals
PHIO
$11.8M
0
TBCH
7698
Turtle Beach Corp
TBCH
$243M
$16K ﹤0.01%
8,812
+4,321
+96% +$10.6K
AXU
7699
DELISTED
Alexco Resource Corp
AXU
$16K ﹤0.01%
10,281
-7,646
-43% -$10.4K
OASM
7700
DELISTED
Oasmia Pharmaceutical AB
OASM
$16K ﹤0.01%
+18,488
New +$17.8K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.